Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Ex-Sanofi Exec Stoeckli Primes Glenmark’s Cancer Therapy Ambitions

Dec 23 2016

• By Anju Ghangurde

Related Content

INTERVIEW: Glenmark's Buschle on how it hopes to 'BEAT' cancer

Aug 21 2014

Amgen's Cancer Strategy: A Multitude Of Modalities In Immuno-Oncology And Beyond

Sep 08 2016

Xencor's Coming Share Issue To Help Fund Immuno-Oncology Pipeline

Dec 02 2016

Related Companies

Glenmark Pharmaceuticals Limited

Sanofi

Roche Holding AG

Amgen, Inc.

Micromet, Inc.

Novartis AG

Xencor, Inc.

Pfizer Inc.

Merck & Co., Inc.

Johnson & Johnson

Genentech, Inc.

Additional Topics

India Asia Pacific Research & Development ImmunoOncology Strategy Biologics

More from R&D

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.